The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.
How Trump's psychedelics executive order could unlock stalled cannabis reform
CNBC·CNBC··1 min read
C
Continue reading on CNBC
This article was sourced from CNBC's RSS feed. Visit the original for the complete story.